Hiromi Konishi

Osaka University of Pharmaceutical Sciences

Papers

1

Total Citations

8

H-Index

1

About

Dr. Hiromi Konishi is a leading gynecologic oncologist whose research centers on optimizing surgical outcomes for women with early-stage cervical cancer. Her most cited work, a 2022 comparative study on minimally invasive versus abdominal radical hysterectomy, directly addresses a critical clinical debate sparked by recent evidence linking MIS to higher recurrence and mortality rates. By meticulously analyzing prognosis between these surgical approaches, Dr. Konishi’s research provides essential data to guide treatment decisions, helping to balance the benefits of less invasive procedures against oncologic safety. With 8 citations in a short time, this study has already influenced surgical practice and patient counseling. Beyond this landmark paper, her broader contributions include refining surgical techniques and investigating factors that affect long-term survival in gynecologic malignancies. Dr. Konishi’s work is vital for clinicians navigating the evolving landscape of cervical cancer surgery, ensuring that patient outcomes remain the central priority in the shift toward minimally invasive methods.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Prognosis between Minimally Invasive and Abdominal Radical Hysterectomy for Patients with Early-Stage Cervical Cancer
8 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Osaka University of Pharmaceutical Sciences

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago